Tapewire

NYSE · USD

INFU

InfuSystem Holdings, Inc

Export transactions ↓
Tapewire entity
6163
SEC CIK
0001337013
Parsed reports
322

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202610
Apr 202600
May 202640
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 17, 2022 Filed May 17, 2022 16:58 UTC
BOYD RALPH FDirector
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014648 · wf-form4_165282106762242.xml · derivative · entry 1

BOYD RALPH F JR · CIK 0001269702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-05-17

F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F2 · derivative.exercise_date: The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:14 UTC
RUIZ THOMAS MARKChief Commercial Officer
GrantRestricted Stock Units · Derivative 12,500 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-014663 · wf-form4_165282201289880.xml · derivative · entry 3

RUIZ THOMAS MARK · CIK 0001768484 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F4 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These restricted stock units will cliff vest on May 17, 2025.

F5 · derivative.expiration_date: These restricted stock units will cliff vest on May 17, 2025.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:14 UTC
RUIZ THOMAS MARKChief Commercial Officer
GrantStock Option (right to buy) · Derivative 18,328 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014663 · wf-form4_165282201289880.xml · derivative · entry 2

RUIZ THOMAS MARK · CIK 0001768484 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,328

Underlying: Common Stock · 18,328 shares

Expires 2032-05-17

F2 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 18,328 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:11 UTC
Lachance CarrieDirector · President and COO
GrantRestricted Stock Units · Derivative 17,727 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-014660 · wf-form4_165282182948302.xml · derivative · entry 3

Lachance Carrie · CIK 0001790024 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,727

Underlying: Common Stock · 17,727 shares

Expires not disclosed

F4 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These restricted stock units will cliff vest on May 17, 2025.

F5 · derivative.expiration_date: These restricted stock units will cliff vest on May 17, 2025.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:11 UTC
Lachance CarrieDirector · President and COO
GrantStock Option (right to buy) · Derivative 25,993 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014660 · wf-form4_165282182948302.xml · derivative · entry 2

Lachance Carrie · CIK 0001790024 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,993

Underlying: Common Stock · 25,993 shares

Expires 2032-05-17

F2 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 25,993 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:10 UTC
Dilorio RichardDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 40,909 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-014659 · wf-form4_165282173532233.xml · derivative · entry 3

Dilorio Richard · CIK 0001706994 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,909

Underlying: Common Stock · 40,909 shares

Expires not disclosed

F4 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: These restricted stock units will cliff vest on May 17, 2025.

F5 · derivative.expiration_date: These restricted stock units will cliff vest on May 17, 2025.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:10 UTC
Dilorio RichardDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 59,984 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014659 · wf-form4_165282173532233.xml · derivative · entry 2

Dilorio Richard · CIK 0001706994 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,984

Underlying: Common Stock · 59,984 shares

Expires 2032-05-17

F2 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 59,984 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:08 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014656 · wf-form4_165282169229861.xml · derivative · entry 2

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-05-17

F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:08 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014654 · wf-form4_165282164473442.xml · derivative · entry 2

GENDRON PAUL ANDREW · CIK 0001769450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-05-17

F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F2 · derivative.exercise_date: The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting.

Read SEC document
May 17, 2022 Filed May 17, 2022 21:00 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $8.58 $0.00
Disclosure

SEC source: 0001628280-22-014651 · wf-form4_165282114907593.xml · derivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-05-17

F3 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.

F4 · derivative.exercise_date: The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 16:22 UTC Exercise / conversionStock Option (right to buy) · Derivative 20,000 $1.98 Strike: $1.98 $39,600.00
Disclosure

SEC source: 0001628280-22-006779 · wf-form4_164787974861578.xml · derivative · entry 3

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 20,000 shares

Expires 2022-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 16:22 UTC SaleCommon Stock 20,000 $10.75 $215,000.00
Disclosure

SEC source: 0001628280-22-006779 · wf-form4_164787974861578.xml · nonDerivative · entry 2

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 16:22 UTC Exercise / conversionCommon Stock 20,000 $1.98 $39,600.00
Disclosure

SEC source: 0001628280-22-006779 · wf-form4_164787974861578.xml · nonDerivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 22:54 UTC
Whitman KevinVP and Corporate Controller
GrantRestricted Stock Units · Derivative 2,250 $0.00 $0.00
Disclosure

SEC source: 0001014108-22-000065 · primary_doc.xml · derivative · entry 4

Whitman Kevin · CIK 0001768114 · VP and Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,250

Underlying: Common Stock · 2,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: These restricted stock units will fully vest on February 18, 2025.

F4 · derivative.expiration_date: These restricted stock units will fully vest on February 18, 2025.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 22:54 UTC
Whitman KevinVP and Corporate Controller
GrantStock Option (right to buy) · Derivative 750 $0.00 Strike: $10.77 $0.00
Disclosure

SEC source: 0001014108-22-000065 · primary_doc.xml · derivative · entry 3

Whitman Kevin · CIK 0001768114 · VP and Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires 2032-02-18

F3 · derivative.exercise_date: The stock option vests 33% per year on the anniversary date of the grant beginning February 18, 2023.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 18:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.98 $0.00
Disclosure

SEC source: 0001014108-22-000062 · primary_doc.xml · derivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vested in twelve monthly installments beginning October 7, 2017.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 18:06 UTC Exercise / conversionCommon Stock 25,000 $1.98 $49,500.00
Disclosure

SEC source: 0001014108-22-000062 · primary_doc.xml · nonDerivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 23:35 UTC PurchaseCommon Stock 10,000 $10.67 $106,700.00
Disclosure

SEC source: 0001014108-22-000061 · primary_doc.xml · nonDerivative · entry 1

GENDRON PAUL ANDREW · CIK 0001769450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
January 24, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 33,519 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · derivative · entry 12

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,332

Underlying: Common Stock · 33,519 shares

Expires 2022-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
SaleCommon Stock 33,519 $15.41 $516,527.79
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 8

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,835

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
January 24, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionCommon Stock 33,519 $2.00 $67,038.00
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 7

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2022 Filed Feb 23, 2022 22:54 UTC
Whitman KevinVP and Corporate Controller
GrantRestricted Stock Units · Derivative 2,648 $0.00 $0.00
Disclosure

SEC source: 0001014108-22-000065 · primary_doc.xml · derivative · entry 2

Whitman Kevin · CIK 0001768114 · VP and Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,648

Underlying: Common Stock · 2,648 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These restricted stock units will fully vest on January 24, 2023.

F2 · derivative.expiration_date: These restricted stock units will fully vest on January 24, 2023.

Read SEC document
January 21, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 149 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · derivative · entry 11

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,851

Underlying: Common Stock · 149 shares

Expires 2022-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 21, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 9,064 $0.00 Strike: $1.98 $0.00
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · derivative · entry 10

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,064 shares

Expires 2022-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 21, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
SaleCommon Stock 149 $15.52 $2,312.48
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 6

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,835

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
January 21, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionCommon Stock 149 $2.00 $298.00
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 5

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,984

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 21, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
SaleCommon Stock 9,064 $15.52 $140,673.28
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 4

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,835

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
January 21, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionCommon Stock 9,064 $1.98 $17,946.72
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 3

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 20, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 15,936 $0.00 Strike: $1.98 $0.00
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · derivative · entry 9

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,064

Underlying: Common Stock · 15,936 shares

Expires 2022-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 20, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
SaleCommon Stock 15,936 $15.98 $254,657.28
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 2

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,835

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
January 20, 2022 Filed Jan 25, 2022 01:22 UTC
Dilorio RichardDirector · President & CEO
Exercise / conversionCommon Stock 15,936 $1.98 $31,553.28
Disclosure

SEC source: 0001014108-22-000026 · primary_doc.xml · nonDerivative · entry 1

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This total includes 78 shares acquired recently through the Company's Employee Stock Purchase Plan.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:16 UTC
Sheehan JeannineChief Administrative Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,943 $0.00 Strike: $4.48 $0.00
Disclosure

SEC source: 0001014108-22-000010 · primary_doc.xml · derivative · entry 7

Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,596

Underlying: Common Stock · 6,943 shares

Expires 2024-04-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:16 UTC
Sheehan JeannineChief Administrative Officer
SaleCommon Stock 6,943 $17.01 $118,100.43
Disclosure

SEC source: 0001014108-22-000010 · primary_doc.xml · nonDerivative · entry 4

Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,607

F1 · price: The price reported in Column 4 is a weighted average price. The shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:16 UTC
Sheehan JeannineChief Administrative Officer
Exercise / conversionCommon Stock 6,943 $4.48 $31,104.64
Disclosure

SEC source: 0001014108-22-000010 · primary_doc.xml · nonDerivative · entry 3

Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2021 Filed Jan 4, 2022 21:16 UTC
Sheehan JeannineChief Administrative Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $4.48 $0.00
Disclosure

SEC source: 0001014108-22-000010 · primary_doc.xml · derivative · entry 6

Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,539

Underlying: Common Stock · 1,000 shares

Expires 2024-04-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2021 Filed Jan 4, 2022 21:16 UTC
Sheehan JeannineChief Administrative Officer
SaleCommon Stock 1,000 $17.00 $17,000.00
Disclosure

SEC source: 0001014108-22-000010 · primary_doc.xml · nonDerivative · entry 2

Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,607

F1 · price: The price reported in Column 4 is a weighted average price. The shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 30, 2021 Filed Jan 4, 2022 21:16 UTC
Sheehan JeannineChief Administrative Officer
Exercise / conversionCommon Stock 1,000 $4.48 $4,480.00
Disclosure

SEC source: 0001014108-22-000010 · primary_doc.xml · nonDerivative · entry 1

Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 29, 2021 Filed Dec 30, 2021 22:53 UTC
RUIZ THOMAS MARKChief Commercial Officer
SaleCommon Stock 76 $17.00 $1,292.00
Disclosure

SEC source: 0001014108-21-000225 · primary_doc.xml · nonDerivative · entry 1

RUIZ THOMAS MARK · CIK 0001768484 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,980

Read SEC document
December 03, 2021 Filed Dec 7, 2021 23:07 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,808 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001014108-21-000213 · primary_doc.xml · derivative · entry 3

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,808 shares

Expires 2022-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 23:07 UTC SaleCommon Stock 5,808 $16.03 $93,102.24
Disclosure

SEC source: 0001014108-21-000213 · primary_doc.xml · nonDerivative · entry 2

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 23:07 UTC Exercise / conversionCommon Stock 5,808 $2.39 $13,881.12
Disclosure

SEC source: 0001014108-21-000213 · primary_doc.xml · nonDerivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2021 Filed Dec 3, 2021 00:10 UTC Exercise / conversionStock Option (right to buy) · Derivative 255 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · derivative · entry 9

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,808

Underlying: Common Stock · 255 shares

Expires 2022-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2021 Filed Dec 3, 2021 00:10 UTC SaleCommon Stock 255 $16.01 $4,082.55
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · nonDerivative · entry 6

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2021 Filed Dec 3, 2021 00:10 UTC Exercise / conversionCommon Stock 255 $2.39 $609.45
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · nonDerivative · entry 5

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 601

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 00:10 UTC Exercise / conversionStock Option (right to buy) · Derivative 2,645 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · derivative · entry 8

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,063

Underlying: Common Stock · 2,645 shares

Expires 2022-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 00:10 UTC SaleCommon Stock 2,645 $16.18 $42,796.10
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · nonDerivative · entry 4

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 00:10 UTC Exercise / conversionCommon Stock 2,645 $2.39 $6,321.55
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · nonDerivative · entry 3

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,991

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2021 Filed Dec 3, 2021 00:10 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,292 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · derivative · entry 7

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,708

Underlying: Common Stock · 1,292 shares

Expires 2022-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2021 Filed Dec 3, 2021 00:10 UTC SaleCommon Stock 1,292 $17.03 $22,002.76
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · nonDerivative · entry 2

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
November 30, 2021 Filed Dec 3, 2021 00:10 UTC Exercise / conversionCommon Stock 1,292 $2.39 $3,087.88
Disclosure

SEC source: 0001014108-21-000208 · primary_doc.xml · nonDerivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.